Elsevier

Ophthalmology

Volume 99, Issue 10, October 1992, Pages 1527-1534
Ophthalmology

Diabetes, Hyperglycemia, and Age-related Maculopathy: The Beaver Dam Eye Study

https://doi.org/10.1016/S0161-6420(92)31770-1Get rights and content

Purpose: The purpose of this study is to examine the association among hyperglycemia, diabetes status, and age-related maculopathy in a population-based study of people between the ages of 43 and 86 years who lived in Beaver Dam, Wisconsin between 1988 and 1990. .

Methods: Age-related maculopathy was determined from stereoscopic fundus photographs.

Results: In the nondiabetic group (n=4291), no relationship was found between glycosylated hemoglobin and any signs of age-related maculopathy. Diabetes status was not associated with early age-related maculopathy. People 75 years of age or older with diabetes (n=85) had a higher frequency of exudative macular degeneration (9.4%) than those without (4.7%) but had similar frequencies of pure geographic atrophy (3.8% for those with diabetes and 3.4% for those without diabetes). The relative risk of exudative macular degeneration in men with diabetes who were 75 years of age or older compared with those who did not have diabetes was 10.2 (95% confidence interval [CI]: 2.4, 43.7); for females it was 1.1 (95% CI: 0.4, 3.0).

Conclusion: These data suggest that diabetes is not related to early age-related maculopathy or geographic atrophy. The relationship of exudative macular degeneration to diabetes in older men, but not women, may be a result of chance. Further longitudinal study of this observation is needed.

References (52)

  • R Klein et al.

    The Beaver Dam Eye Study. Retinopathy in adults with newly discovered and previously diagnosed diabetes mellitus

    Ophthalmology

    (1992)
  • SL Hyer et al.

    A two-year followup study of serum insulinlike growth factor-I in diabetics with retinopathy

    Metabolism

    (1989)
  • National Society to Prevent Blindness. Vision Problems in the U.S.: Data Analysis

    (1980)
  • FL Ferris

    Senile macular degeneration: review of epidemiologic features

    Am J Epidemiol

    (1983)
  • Recurrent choroidal neovascularization after argon laser photocoagulation for neovascular maculopathy

    Arch Ophthalmol

    (1986)
  • Argon laser photocoagulation for neovascular maculopathy. Five-year results from randomized clinical trials

    Arch Ophthalmol

    (1991)
  • E Friedman

    Choroidal blood flow. Pressure-flow relationships

    Arch Ophthalmol

    (1970)
  • AW Fryczkowski et al.

    Changes in the diabetic choroidal vasculature: scanning electron microscopy findings

    Ann Ophthalmol

    (1988)
  • MV Miceli et al.

    Cultured retinal pigment epithelium cells from donors with type I diabetes show an altered insulin response

    Invest Ophthalmol Vis Sci

    (1991)
  • S Chakrabarti et al.

    Augmented polyol pathway activity and retinal pigment epithelial permeability in the diabetic BB rat

    Diabetes Res Clin Pract

    (1990)
  • CW Marano et al.

    Biochemical manifestations of diabetes mellitus in microscopic layers of the cornea and retina

    Diabetes Metab Rev

    (1989)
  • JS Vidaurri et al.

    Association between drusen and some of the risk factors for coronary artery disease

    Ophthalmologica

    (1984)
  • P Algvere et al.

    Retinal microangiopathy and pigment epithelial lesions in subjects with normal, borderline, and decreased oral glucose tolerance

    Br J Ophthalmol

    (1985)
  • LG Hyman et al.

    Senile macular degeneration: a case-control study

    Am J Epidemiol

    (1983)
  • BA Maltzman et al.

    Senile macular degeneration and risk factors: a case-control study

    Ann Ophthalmol

    (1979)
  • HA Kahn et al.

    The Framingham Eye Study. II. Association of ophthalmic pathology with single variables previously measured in the Framingham Heart Study

    Am J Epidemiol

    (1977)
  • Cited by (0)

    Supported by grant EY06594 from the National Eye Institute/NIH, Bethesda, Maryland (Drs. R. Klein and B. E. K. Klein).

    View full text